Medical and Endoscopic Management of Crohn Disease

Parakkal Deepak1, Daniel R Ludwig2, Jeff L Fidler3

  • 1Washington University Inflammatory Bowel Diseases Center, Division of Gastroenterology, Washington University in Saint Louis School of Medicine, St. Louis, MO.

Insights

This review clarifies Crohn disease risk stratification and treatment guidelines from major international organizations. It highlights imaging roles and therapeutic targets for better patient outcomes.

Area of Science:

  • Gastroenterology and Inflammatory Bowel Diseases
  • Medical Imaging in Crohn Disease
  • Therapeutic Strategies for Crohn Disease

Background:

  • Current Crohn disease management involves risk stratification into low-risk (mild-moderate) and high-risk (moderate-severe) categories.
  • Established guidelines from international organizations guide treatment decisions for different risk profiles.

Purpose of the Study:

  • To review current Crohn disease classification and risk stratification approaches.
  • To detail recommended treatment strategies based on international guidelines.
  • To summarize the pipeline of novel Crohn disease therapies and explore imaging's role.

Main Methods:

  • Review of current literature and guidelines from key inflammatory bowel disease organizations.
  • Analysis of magnetic resonance enterography and pelvis imaging findings relevant to clinical teams.
  • Exploration of endoscopic and radiological targets within a treat-to-target framework.

Main Results:

  • Provides a Q&A format to understand Crohn disease risk stratification.
  • Details guideline-recommended treatments for mild-moderate and moderate-severe Crohn disease.
  • Summarizes emerging therapies and the communication of imaging findings in multidisciplinary care.

Conclusions:

  • Accurate risk stratification is crucial for tailoring Crohn disease treatment.
  • Multidisciplinary collaboration, informed by imaging, optimizes patient outcomes.
  • A treat-to-target approach using endoscopic and radiological markers is essential for effective Crohn disease management.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
302
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
299
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
295
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
320
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
503
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
179